Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-09-04

Clinical Trial Update: Resveratrol and Type 2 Diabetes [NA]

View source ↗

Summary

This is an update on a clinical trial evaluating resveratrol for Type 2 diabetes; the status and phase are not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resveratrol (resveratrol)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Type 2 Diabetes | NA | Status: UNKNOWN